GO
| HSI1 | 24,856.43 | 0.00 | -- |
| HSCEI1 | 8,389.93 | 0.00 | -- |
| Back Zoom + Zoom - Block Traded | |
|
2026-03-26 17:56:49 INNOVENT BIO (01801.HK) announced its full-year results for the year ended December 31, 2025. Revenue reached RMB13.042 billion, a YoY increase of 38.4%, exceeding RMB10 billion for the first time. The company turned into a profit of RMB814 million, achieving its first full-year profit, compared to a loss of RMB94.631 million in the same period last year, with an EPS of RMB0.48. No dividend was declared. ~ AASTOCKS Financial News Website: www.aastocks.com | |